NHS National Framework for Golimumab (Renewal)
Estimated value
£105.0m
goods
Awarded value
—
Suppliers
0
Lots
1
0 awarded
Published
10 Mar 2026
This is a preliminary market engagement notice
Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.
Description
NHS National Framework for Golimumab (Renewal) Suppliers who are planning to introduce the molecules detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net
Scope
- Reference
- CM/TNS/26/5746
- Total value
- £105,000,000 excluding VAT£126,000,000 including VATAbove the relevant threshold
- Commercial tool
- Standalone contract
- Contract dates
- 01 Nov 2026 to 31 Oct 2027Possible extension to 31 Oct 2029
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- North East England, United KingdomNorth West England, United KingdomEast Midlands, United KingdomWest Midlands, United KingdomEast of England, United KingdomSouth East England, United KingdomSouth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Procedure
- Open procedure